ALC
ALCIDION FPO [ALC]
Healthcare · ASX Small Cap
$0.1000 -4.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -8First seen: 2026-02-25
Score Breakdown
Technical37
Catalyst50
Sentiment50
Fundamental88
Momentum64
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Sustained volume spike (2.4x median) on DOWN trend
- Near support level (potential bounce)
- Cash positive / operating cashflow positive
- Low P/S ratio (3.5x)
- Strong revenue growth (+29%)
- Piotroski F-Score strong (7/9)
- CANSLIM I: Institutional ownership (11%)
- Positive 12-1 momentum (+40%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD bearish crossover
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE H1 FY26 Results Presentation
NONE H1 FY26 Results Release
NONE H1 FY26 Appendix 4D and Half Year Report
Recent ASX Announcements
| 2026-02-25 | H1 FY26 Results Presentation PRICE SENSITIVE |
| 2026-02-25 | H1 FY26 Results Release PRICE SENSITIVE |
| 2026-02-25 | H1 FY26 Appendix 4D and Half Year Report PRICE SENSITIVE |
| 2026-02-18 | Alcidion H1 FY26 Results and Investor Webcast Notification |
| 2026-02-18 | Dual AU and UK Medical Device Registration for AI Capability PRICE SENSITIVE |
Key Metrics
$141.0M
Market Cap
1.2M
Avg Volume
2.4x
Vol Ratio
$0.06 — $0.14
52-Week Range
N/A
Short Interest
N/A
Cash Runway
1.9%
ROE
4.1%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 74% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 11% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #69 of 119 · Sector avg: 51
View all Healthcare signals →